2022
Medical Therapy with Antimuscarinics and ß3-Agonists
Goodridge S, Rickey L. Medical Therapy with Antimuscarinics and ß3-Agonists. 2022, 147-164. DOI: 10.1007/978-3-030-84352-6_8.Peer-Reviewed Original ResearchOveractive bladderManagement of OABTreatment of OABMedical therapy optionsSecond-line therapyFirst-line treatmentSide effect profileBeta-3 agonistQuality of lifeMedical therapyEffect profileTherapy optionsDrug classesComparative efficacyBehavioral modificationAntimuscarinicsBladderTherapyEfficacyTreatmentPharmacotherapyPatientsAgonistsLarge subsetProgression
2017
Evaluation and Management of Voiding Dysfunction Following Surgery for Mesh Excision
Rickey L, Russo A. Evaluation and Management of Voiding Dysfunction Following Surgery for Mesh Excision. Current Bladder Dysfunction Reports 2017, 12: 252-259. DOI: 10.1007/s11884-017-0427-2.Peer-Reviewed Original ResearchOveractive bladderVoiding dysfunctionEvidence-based treatment recommendationsPersistent voiding dysfunctionStress urinary incontinenceIncomplete emptyingStorage symptomsUrinary retentionVoiding symptomsUrinary incontinenceMidurethral slingMesh excisionClear management strategiesPrimary complaintOptimal treatmentTreatment recommendationsHigh success rateFurther interventionParticular patientPatientsDysfunctionRecent FindingsTheStandardized definitionsLimited evidenceSymptoms
2008
Botulinum Toxin for Lower Urinary Tract Symptoms in Women
Rickey L. Botulinum Toxin for Lower Urinary Tract Symptoms in Women. Urogynecology 2008, 14: 135-161. DOI: 10.1097/spv.0b013e318177eb4f.Peer-Reviewed Original ResearchUrinary tract symptomsTract symptomsBotulinum toxinLower Urinary Tract SymptomsLower urinary tractPelvic floor disordersStandard therapyLow morbidityMedical therapyPatients' qualityUrinary tractPelvic floorIntractable conditionSafe alternativeSignificant distressChallenging groupInnovative treatmentsSymptomsTherapyWomenTreatmentToxinMorbidityPatientsAbstract Women